Is Lincoln Tech Accredited

Celerion is being re-accredited for protecting clinical research participants

LINCOLN, Nebraska, Jan. - Clinical Research Organization Celerion announced today that it has been re-accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP). In order to be re-accredited, the company's personnel have undergone a rigorous review of clinical research practices at its facilities.

All previous site visits have also resulted in AAHRPP accreditation.

"As the only contract research organization (CRO) to receive this AAHRPP accreditation, Celerion continues to position itself at the forefront of the highest ethical and safety standards in clinical research," said Philip Bach, the company's vice president of global clinical research.

"It is particularly gratifying to be able to achieve this amid a unique pandemic and its unique demanding requirements," he added. "We are also pleased that the AAHRPP has praised our recruiting and recruiting practices during this time when informed consent is paramount."

The AAHRPP regularly evaluates the quality of the programs for the protection of human research at the participating research organizations in order to better promote ethical research and to ensure that all participants in a research project on humans are respected and protected from unnecessary harm.

Organizations seeking accreditation or reaccreditation must demonstrate in-depth policies, procedures, and practices, as well as their ongoing commitment to ensuring the protection of human rights in clinical research.

About Celerion

As a recognized, world-leading provider of early clinical research services, Celerion "translates" science into medicine through scientific excellence, medical expertise and broad clinical operating experience.

For fifty years, Celerion has been the industry leader in conducting safety / tolerability, pharmacokinetic and pharmacodynamics studies in highly controlled clinical settings such as first-in-human dose escalation, drug interactions, cardiac safety, bioequivalence and bioavailability, metabolism and excretion as well pharmacokinetic evaluations in patients with impaired renal or hepatic function.

Celerion optimizes this with superior data management, biostatistics, clinical monitoring and bioanalytical services. Our ongoing mission is to help our customers get their medicines to market in a timely manner so that people in need around the world can benefit.

Further information is available at www.gastechevent.com.

Inquiries & contact:

Lorraine M. Rusch, Ph.D., 914-548-1690, [email protected]
Logo - mma.prnewswire.com/media/414617/Celerion_Logo.jpg